Our story
Our brands
Our commitments
News & features
EN
Return to menu
Connecting care across the world through our global reach
Our locations
Learn about Kenvue in your area
Argentina
Spanish
Brazil
Portuguese
Central America
Spanish
Chile
Spanish
Colombia
Spanish
Germany
German
India
English
Japan
Japanese
Mexico
Spanish
United Kingdom
English
Global site languages
Deutsch
English
Español
Français
Italiano
日本語
中文
Português
Investors
Healthcare professionals
Careers
Media
Investors
Healthcare professionals
Careers
Media
Menu
Close
Our story
Our brands
Our commitments
News & features
EN
Return to menu
Connecting care across the world through our global reach
Our locations
Learn about Kenvue in your area
Argentina
Spanish
Brazil
Portuguese
Central America
Spanish
Chile
Spanish
Colombia
Spanish
Germany
German
India
English
Japan
Japanese
Mexico
Spanish
United Kingdom
English
Global site languages
Deutsch
English
Español
Français
Italiano
日本語
中文
Português
Search Query
Search
Show Search
Search results - A new view of care
Search
604 Results
604 Results
Sort By
Relevance
Newest
Oldest
Johnson & Johnson announces Kenvue as the name for planned new consumer health company
Modern name, purpose and visual identity mark inspiring next chapter for maker of iconic, trusted brands, including Tylenol®, Neutrogena®, Listerine® and BAND-AID® Brand
September 28, 2022
No more white cast: This groundbreaking mineral sunscreen looks invisible on every skin tone
Kenvue skin health & beauty brands shine at 2023 American Academy of Dermatology meeting
April 14, 2023
·
Meghan Harding
7 essential travel items to bring on your next road trip
September 6, 2023
Kenvue initiates quarterly cash dividend
July 20, 2023
Kenvue breaks ground on new global headquarters in Summit, New Jersey
Maker of iconic brands such as Neutrogena
®
, Listerine
®
, Aveeno
®
and Tylenol
®
to establish 290,000 sq. ft global headquarters, including newly constructed, state-of-the-art Science and Innovation Lab
April 24, 2024
Kenvue reports first quarter 2024 results
- Q1’24: Net sales increased 1.1% to $3.9 billion with organic growth
1
of 1.9%
-
Q1’24: Diluted earnings per share of $0.15; adjusted diluted earnings per share
1
of $0.28
- Reaffirms fiscal year 2024 outlook
May 7, 2024
Previous
12 of 87
Next
